Trial
NCT00088972
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Breast Cancer
Intervention
celecoxib
Why stopped
Study closed due to poor accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-10